药物诱导睡眠内镜上气道塌陷模式与上下颌前徙术
前瞻性病例系列纳入19例阻塞性睡眠呼吸暂停患者,先行下颌前徙装置治疗再行上下颌前徙术。14例完整数据显示术后呼吸暂停低通气指数从基线40.2±25.6次/小时降至9.9±7.2次/小时(P=.0001),基线软腭完全同心圆塌陷似乎不是手术疗效的负面预测因素,且术后塌陷均消除。
要点
- 上下颌前徙术使呼吸暂停低通气指数从基线40.2±25.6降至9.9±7.2次/小时(P=.0001)。
- 基线软腭完全同心圆塌陷似乎不是上下颌前徙术疗效的负面预测因素。
- 术后药物诱导睡眠内镜显示所有患者软腭完全同心圆塌陷均消除(P=.0159)。
核心结论
- 软腭完全同心圆塌陷似乎不是上下颌前徙术以呼吸暂停低通气指数下降衡量疗效的负面预测因素。
- 上下颌前徙术可能消除软腭完全同心圆塌陷,可能成为此类阻塞性睡眠呼吸暂停患者的解决方案,并拓宽个体化医疗与联合治疗的视角。
- 作者指出需要大样本才能获得确定性结果。
研究设计与样本
- 前瞻性病例系列,19例诊断为阻塞性睡眠呼吸暂停的患者先行下颌前徙装置治疗,随后行上下颌前徙术。
- 14例获得完整数据集:男8例、女6例,平均年龄51±7岁,体重指数25.6±3.7 kg/m2,基线呼吸暂停低通气指数40.2±25.6次/小时睡眠。
- 在上下颌前徙术前后评估上气道塌陷模式,比较基线、下颌前徙装置治疗期间及术后呼吸暂停低通气指数。
主要发现
- 上下颌前徙术使呼吸暂停低通气指数降至9.9±7.2次/小时睡眠(P=.0001)。
- 8例患者较下颌前徙装置治疗获得额外呼吸暂停低通气指数下降(P=.0113)。
- 14例中6例(43%)基线存在软腭完全同心圆塌陷。
- 基线年龄、体重指数和呼吸暂停低通气指数在有无软腭完全同心圆塌陷的患者间无显著差异。
- 术后药物诱导睡眠内镜显示所有患者软腭完全同心圆塌陷均消除(P=.0159)。
关键数值与推荐
- 基线存在软腭完全同心圆塌陷者术后呼吸暂停低通气指数下降P=.0145,不存在者P=.0075。
临床怎么用
- 作者认为上下颌前徙术可能消除软腭完全同心圆塌陷,可能成为具有该表型的阻塞性睡眠呼吸暂停患者的解决方案。
- 作者指出需要大样本才能获得确定性结果。
局限性
- 作者指出需要大样本才能获得确定性结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: To evaluate upper airway (UA) collapse patterns during drug-induced sleep endoscopy (DISE) and maxillomandibular advancement (MMA) surgery outcome, paying particular attention to the DISE phenotype complete concentric collapse at the level of the palate (CCCp). STUDY DESIGN: Prospective case series. METHODS: Nineteen patients diagnosed with obstructive sleep apnea (OSA) prospectively underwent mandibular advancement device (MAD) treatment followed by MMA surgery. UA collapse patterns were evaluated before and after MMA surgery. Baseline apnea-hypopnea index (AHI) was compared with AHI during MAD treatment and after MMA surgery. UA collapse patterns and the presence of baseline CCCp were assessed. AHI differences between patients with and without CCCp after MMA surgery were compared. RESULTS: In 14 patients, a full dataset was obtained: 8/6 (male/female), mean age = 51 ± 7 years, body mass index (BMI) = 25.6 ± 3.7 kg/m2 , and baseline AHI = 40.2 ± 25.6 per hour of sleep. MMA surgery reduced AHI to 9.9 ± 7.2 per hour of sleep (P = .0001). Eight patients benefited from additional AHI reduction compared to MAD treatment (P = .0113). Six out of 14 (43%) patients showed baseline CCCp. Baseline patient characteristics (age, BMI, and AHI) did not significantly differ between patients with and without CCCp. AHI was equally reduced after MMA, whether (P = .0145) or not (P = .0075) CCCp was present at baseline. All patients showed resolution of CCCp (P = .0159) during postoperative DISE. CONCLUSIONS: CCCp seems not to be a negative predictor for MMA surgery outcome measured by AHI reduction. Furthermore, MMA is likely to eliminate CCCp. Therefore, MMA might be a solution for OSA patients showing CCCp and broadens the perspective for personalized medicine and combination therapy. However, a large sample is required for definitive results. LEVEL OF EVIDENCE: 4 Laryngoscope, 130:E268-E274, 2020.
引用
- Kastoer C, Op de Beeck S, Dom M, et al. Drug-Induced Sleep Endoscopy Upper Airway Collapse Patterns and Maxillomandibular Advancement. Laryngoscope. 2019. PMID: 31034634. doi:10.1002/lary.28022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。